{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:32:22Z","timestamp":1790062342594,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Program of Precision Medicine from National Key Research and Development Plan","award":["2016YFC0905700"],"award-info":[{"award-number":["2016YFC0905700"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Dyskeratosis congenita (DC) is a rare genetic disorder of poor telomere maintenance. Pulmonary fibrosis (PF) related to DC is rarely reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 23-year-old student presented with a four-year history of progressive cough and exertional dyspnea. Physical examination was remarkable for typical mucocutaneous abnormalities. Chest computerized tomography scan revealed interstitial fibrosis. Testing of peripheral blood leukocytes confirmed that his telomeres were 30th percentile of age-matched controls. A heterozygous missense mutation located in exon 22 of PARN gene was identified in the patient by whole exome sequencing. The patient refused danazol therapy and lung transplantation, and died of respiratory failure 2\u00a0years later. In addition, this case and 26 reported cases of DC-related PF identified through the comprehensive search of PubMed, Web of Science, WANFANG and CNKI were reviewed. Later-onset PF was observed in 11 patients (40.7%). Radiological usual interstitial pneumonia (UIP) pattern or possible UIP pattern was noted only in half of patients. However, histopathological UIP or probable UIP patterns were found in 63.6% of patients. Age at bone marrow failure (BMF) and the frequency of normal to mild thrombocytopenia in later-onset patients was significantly higher than in early-onset patients (p\u2009=\u20090.017 and p\u2009=\u20090.021, respectively). Age at PF and age at BMF in DC patients with TERC\/TERT variants was significantly higher than in those with TINF2 variants or DKC1\/NHP2 variants (p\u2009=\u20090.004 and p\u2009=\u20090.003, respectively). The patients with TERT\/TERC\/RTEL1\/PARN variants had a significantly better transplant-free survival than those with TINF2 variants or DKC1\/NHP2 variants (p\u2009&lt;\u20090.05). Patients who underwent surgical lung biopsy had significantly worse transplant-free survival than those without lung biopsy (p\u2009=\u20090.042). Worse survival was found in patients with immunosuppression therapy than in those without (p\u2009=\u20090.012).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>It is common for DC-associated PF to occur later in life without significant hematological manifestations. Mutations in the genes encoding different components of the telomere maintenance pathway were associated with clinical phenotypes and prognosis. PF caused by DC should be kept in mind by clinicians in the differential diagnosis of patients with unexplained PF and should be excluded before diagnostic surgical lung biopsy is undertaken or empirical immunosuppression therapy is prescribed.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12890-021-01645-w","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T12:03:14Z","timestamp":1630670594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review"],"prefix":"10.1186","volume":"21","author":[{"given":"Ping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"issue":"4","key":"1645_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.mayocp.2018.03.020","volume":"46","author":"PM Barbaro","year":"2016","unstructured":"Barbaro PM, Ziegler DS, Reddel RR. The wide-ranging clinical implications of the short telomere syndromes. Intern Med J. 2016;46(4):393\u2013403. https:\/\/doi.org\/10.1016\/j.mayocp.2018.03.020.","journal-title":"Intern Med J"},{"key":"1645_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1586\/ehm.13.23","volume":"6","author":"BJ Ballew","year":"2013","unstructured":"Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2013;6:327\u201337. https:\/\/doi.org\/10.1586\/ehm.13.23.","journal-title":"Expert Rev Hematol"},{"key":"1645_CR3","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.480","author":"I Dokal","year":"2011","unstructured":"Dokal I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program. 2011. https:\/\/doi.org\/10.1182\/asheducation-2011.1.480.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1645_CR4","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1182\/blood-2005-07-2622","volume":"107","author":"TJ Vulliamy","year":"2006","unstructured":"Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107:2680\u20135. https:\/\/doi.org\/10.1182\/blood-2005-07-2622.","journal-title":"Blood"},{"issue":"1","key":"1645_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.humpath.2014.10.003","volume":"46","author":"LA Dvorak","year":"2015","unstructured":"Dvorak LA, Vassallo R, Kirmani S, Johnson G, Hartman TE, Tazelaar HD, et al. Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases. Hum Pathol. 2015;46(1):147\u201352. https:\/\/doi.org\/10.1016\/j.humpath.2014.10.003.","journal-title":"Hum Pathol"},{"key":"1645_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00209-2019","author":"N Giri","year":"2019","unstructured":"Giri N, Ravichandran S, Wang Y, Gadalla SM, Alter BP, Fontana J, et al. Prognostic significance of pulmonary function tests in dyskeratosis congenita, a telomere biology disorder. ERJ Open Res. 2019. https:\/\/doi.org\/10.1183\/23120541.00209-2019.","journal-title":"ERJ Open Res"},{"key":"1645_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2326-11-3","volume":"11","author":"N Giri","year":"2011","unstructured":"Giri N, Lee R, Faro A, Huddleston CB, White FV, Alter BP, et al. Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: case report and systematic literature review. BMC Blood Disord. 2011;11:3. https:\/\/doi.org\/10.1186\/1471-2326-11-3.","journal-title":"BMC Blood Disord"},{"issue":"10","key":"1645_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.10.e47","volume":"30","author":"RM Cawthon","year":"2002","unstructured":"Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30(10): e47. https:\/\/doi.org\/10.1093\/nar\/30.10.e47.","journal-title":"Nucleic Acids Res"},{"key":"1645_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.seminhematol.2006.04.001","volume":"43","author":"T Vulliamy","year":"2006","unstructured":"Vulliamy T, Dokal I. Dyskeratosis congenita. Semin Hematol. 2006;43:157\u201366. https:\/\/doi.org\/10.1053\/j.seminhematol.2006.04.001.","journal-title":"Semin Hematol"},{"issue":"6","key":"1645_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An Official ATS\/ERS\/JRS\/ALAT Statement: Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824. https:\/\/doi.org\/10.1164\/rccm.2009-040GL.","journal-title":"Am J Respir Crit Care Med"},{"key":"1645_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa011","author":"M Benyelles","year":"2020","unstructured":"Benyelles M, O\u2019Donohue MF, Kermasson L, Lainey E, Borie R, Lagresle-Peyrou C, et al. NHP2 deficiency impairs rRNA biogenesis and causes\u00a0pulmonary fibrosis\u00a0and H\u00f8yeraal-Hreidarsson syndrome. Hum Mol Genet. 2020. https:\/\/doi.org\/10.1093\/hmg\/ddaa011.","journal-title":"Hum Mol Genet"},{"issue":"19","key":"1645_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010724","volume":"97","author":"H Du","year":"2018","unstructured":"Du H, Guo Y, Ma D, Tang K, Cai D, Luo Y, et al. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita. Medicine (Baltimore). 2018;97(19): e0724. https:\/\/doi.org\/10.1097\/MD.0000000000010724.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"1645_CR13","doi-asserted-by":"publisher","first-page":"E48","DOI":"10.1002\/ppul.23235","volume":"50","author":"B Zlateska","year":"2015","unstructured":"Zlateska B, Ciccolini A, Dror Y. Treatment of dyskeratosis congenita-asscociated pulmonary fibrosis with danazol. Pediatr Pulmonol. 2015;50(12):E48-51. https:\/\/doi.org\/10.1002\/ppul.23235.","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"1645_CR14","first-page":"701","volume":"38","author":"K Zhang","year":"2015","unstructured":"Zhang K, Li H, Lu R, Kong X, Bai Y, Jiang N, et al. A case report of pulmonary fibrosis complicating dyskeratosis congenita. Chin J Tubere Respir Dis. 2015;38(9):701\u20133.","journal-title":"Chin J Tubere Respir Dis"},{"issue":"6","key":"1645_CR15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1183\/09031936.00149113","volume":"42","author":"A Fukuhara","year":"2013","unstructured":"Fukuhara A, Tanino Y, Ishii T, Inokoshi Y, Saito K, Fukuhara N, et al. Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation. Eur Respir J. 2013;42(6):1757\u20139. https:\/\/doi.org\/10.1183\/09031936.00149113.","journal-title":"Eur Respir J"},{"issue":"3","key":"1645_CR16","first-page":"221","volume":"30","author":"S Hisata","year":"2013","unstructured":"Hisata S, Sakaguchi H, Kanegane H, Hidaka T, Shiihara J, Ichinose M, et al. A novel missense mutation of DKC1 in dyskeratosis congenita with pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(3):221\u20135.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"1645_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4046\/trd.2013.74.2.70","volume":"74","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Kim KJ, Lee KH, Shin KC, Chung JH, Hyun MS, et al. Interstitial lung disease in a patient with dyskeratosis congenita. Tuberc Respir Dis (Seoul). 2013;74(2):70\u20133. https:\/\/doi.org\/10.4046\/trd.2013.74.2.70.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"6","key":"1645_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0025-6196(11)61538-3","volume":"80","author":"JP Utz","year":"2005","unstructured":"Utz JP, Ryu JH, Myers JL, Michels VV. Usual interstitial pneumonia complicating dyskeratosis congenita. Mayo Clin Proc. 2005;80(6):817\u201321.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"1645_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1442-200X.2003.01820.x","volume":"45","author":"S Kilic","year":"2003","unstructured":"Kilic S, Kose H, Ozturk H. Pulmonary involvement in a patient with dyskeratosis congenita. Pediatr Int. 2003;45(6):740\u20132.","journal-title":"Pediatr Int"},{"issue":"11","key":"1645_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/thorax.56.11.891","volume":"56","author":"WF Safa","year":"2001","unstructured":"Safa WF, Lestringant GG, Frossard PM. X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation. Thorax. 2001;56(11):891\u20134.","journal-title":"Thorax"},{"issue":"4","key":"1645_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/sj.bmt.1700674","volume":"19","author":"M Yabe","year":"1997","unstructured":"Yabe M, Yabe H, Hattori K, Morimoto T, Hinohara T, Takakura I, et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;19(4):389\u201392.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"1645_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2169\/internalmedicine.33.226","volume":"33","author":"S Imokawa","year":"1994","unstructured":"Imokawa S, Sato A, Toyoshima M, Yoshitomi A, Tamura R, Suda T, et al. Dyskeratosis congenita showing usual interstitial pneumonia. Intern Med. 1994;33(4):226\u201330.","journal-title":"Intern Med"},{"issue":"4","key":"1645_CR23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1183\/09031936.93.05040497","volume":"5","author":"F Verra","year":"1992","unstructured":"Verra F, Kouzan S, Saiag P, Bignon J, de Cremoux H. Bronchoalveolar disease in dyskeratosis congenita. Eur Respir J. 1992;5(4):497\u20139.","journal-title":"Eur Respir J"},{"key":"1645_CR24","doi-asserted-by":"publisher","first-page":"e10680","DOI":"10.1371\/journal.pone.0010680","volume":"5","author":"A Diaz de Leon","year":"2010","unstructured":"Diaz de Leon A, Cronkhite JT, Katzenstein AL, Godwin JD, Raghu G, Glazer CS, et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS ONE. 2010;5:e10680. https:\/\/doi.org\/10.1371\/journal.pone.0010680.","journal-title":"PLoS ONE"},{"issue":"5","key":"1645_CR25","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1172\/JCI78963","volume":"125","author":"H Tummala","year":"2015","unstructured":"Tummala H, Walne A, Collopy L, Cardoso S, de la Fuente J, Lawson S, et al. Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. J Clin Invest. 2015;125(5):2151\u201360. https:\/\/doi.org\/10.1172\/JCI78963.","journal-title":"J Clin Invest"},{"key":"1645_CR26","doi-asserted-by":"publisher","unstructured":"Burris AM,\u00a0Ballew BJ,\u00a0Kentosh JB, Turner CE,\u00a0Norton SA;\u00a0NCI DCEG Cancer Genomics Research Laboratory, et al. Hoyeraal-Hreidarsson syndrome due to PARN Mutations: fourteen years of follow-up. Pediatr Neurol 2016; 56: 62\u201368.e1. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.12.005.","DOI":"10.1016\/j.pediatrneurol.2015.12.005"},{"issue":"5","key":"1645_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/ng.3278","volume":"47","author":"BD Stuart","year":"2015","unstructured":"Stuart BD, Choi J, Zaidi S, Xing C, Holohan B, Chen R, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet. 2015;47(5):512\u20137. https:\/\/doi.org\/10.1038\/ng.3278.","journal-title":"Nat Genet"},{"issue":"12","key":"1645_CR28","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/humu.23898","volume":"40","author":"LM Dodson","year":"2019","unstructured":"Dodson LM, Baldan A, Nissbeck M, Gunja SMR, Bonnen PE, Aubert G, et al. From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants. Hum Mutat. 2019;40(12):2414\u201329. https:\/\/doi.org\/10.1002\/humu.23898.","journal-title":"Hum Mutat"},{"key":"1645_CR29","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1182\/blood-2008-05-153445","volume":"112","author":"AJ Walne","year":"2008","unstructured":"Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I. TINF2 gene mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood. 2008;112:3594\u2013600. https:\/\/doi.org\/10.1182\/blood-2008-05-153445.","journal-title":"Blood"},{"issue":"3","key":"1645_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.chest.2017.02.011","volume":"152","author":"P Wang","year":"2017","unstructured":"Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, et al. Pathologic findings and prognosis in a large prospective cohort of chronic hypersensitivity pneumonitis. Chest. 2017;152(3):502\u20139. https:\/\/doi.org\/10.1016\/j.chest.2017.02.011.","journal-title":"Chest"},{"issue":"3","key":"1645_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","volume":"200","author":"CA Newton","year":"2019","unstructured":"Newton CA, Zhang D, Oldham JM, Kozlitina J, Ma SF, Martinez FJ, et al. Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(3):336\u201347. https:\/\/doi.org\/10.1164\/rccm.201809-1646OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1645_CR32","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1402582.","journal-title":"N Engl J Med"},{"issue":"3","key":"1645_CR33","doi-asserted-by":"publisher","first-page":"1701875","DOI":"10.1183\/13993003.01875-2017","volume":"51","author":"A Justet","year":"2018","unstructured":"Justet A, Thabut G, Manali E, Molina Molina M, Kannengiesser C, Cadranel J, Cottin V, Gondouin A, Nunes H, Magois E, Tromeur C, Prevot G, Papiris S, Marchand-Adam S, Gamez AS, Reynaud-Gaubert M, Wemeau L, Crestani B, Borie R. Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation. Eur Respir J. 2018;51(3):1701875. https:\/\/doi.org\/10.1183\/13993003.01875-2017.","journal-title":"Eur Respir J"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01645-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T15:01:02Z","timestamp":1673190062000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01645-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1645"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01645-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"8 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Peking Union Medical College Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}